Table 2.
HPV prevalences and number of HPV types detected in males and females, overall and among sexually experienced participants
| HPV types detecteda | All Participants (N = 993) | Sexually Experienced Participants (N = 748) | ||||
|---|---|---|---|---|---|---|
| Females (N = 500) n (%) |
Males (N = 493) n (%) |
Chi-square P-value |
Females (N = 372) n (%) |
Males (N = 376) n (%) |
Chi-square P-value |
|
| Any HPV | 315 (63.0) | 155 (31.4) | <0.001 | 280 (75.3) | 140 (37.2) | <0.001 |
| Quadrivalent | 105 (21.0) | 48 (9.7) | <0.001 | 99 (26.6) | 43 (11.4) | <0.001 |
| LR-HPV6/11 | 55 (11.0) | 27 (5.5) | 0.002 | 52 (14.0) | 23 (6.1) | <0.001 |
| HR-HPV16/18 | 71 (14.2) | 26 (5.3) | <0.001 | 67 (18.0) | 25 (6.7) | <0.001 |
| Non-quadrivalent | 302 (60.4) | 140 (28.4) | <0.001 | 270 (72.6) | 128 (34.0) | <0.001 |
| Other HR-HPV | 253 (50.6) | 104 (21.1) | <0.001 | 230 (61.8) | 95 (25.3) | <0.001 |
| Other LR-HPV | 217 (43.4) | 72 (14.6) | <0.001 | 196 (52.7) | 68 (18.1) | <0.001 |
| Number of HPV types detected (among HPV + ) | <0.001 | <0.001 | ||||
| 1 | 84 (26.7) | 92 (59.4) | 62 (22.1) | 81 (57.9) | ||
| 2–4 | 150 (47.6) | 55 (35.5) | 141 (50.4) | 51 (36.4) | ||
| ≥5 | 81 (25.7) | 8 (5.2) | 77 (27.5) | 8 (5.7) | ||
HPV, human papillomavirus; LR, low risk; HR, high-risk.
Quadrivalent: HPV 6, 11, 16, 18; Quadrivalent LR: HPV 6,11; Quadrivalent HR: HPV 16, 18; Non-quadrivalent: HPV 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 66, 68, 69, 70, 73, 82; Non-quadrivalent other HR: HPV 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68; Non-quadrivalent other LR: HPV 26, 40, 42, 43, 44, 53, 54, 61, 69, 70, 73, 82.
a
HPV type categories are not mutually exclusive or exhaustive; participants may be represented in more than one category due to multiple-type infections.